Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ECO
    --Site Admin--
    • Oct 2007
    • 1360

    #1

    If you could use next-gen sequencing technology to answer any question....

    ...what small study would you do?

    This is intended as a bit of fantasy, but a serious question, as I've often considered this question:

    If you could do one small set of focused samples what would they be and what platform would you use to answer the question?

    Cost/labor/your ability to analyze the data is not to be considered...we're talking pure scientific curiousity. Let's limit it to say one run on a GA/SOLiD, or 2-3 runs on 454, or a combination of short/long reads. But no more than 8-16 samples.

    Moon rocks? Environmental mining? The fauna scraped off your windshield after a cross country drive? Swabs from a subway seat?
  • cariaso
    Member
    • Jan 2008
    • 31

    #2
    N timepoints for 3 patients from birth to death. Patients are triplets (twins+1) . The first two would be raised in the same environment, the third would be separated at birth. Sequence the epigenome. No clear platform preference.

    No triplets were harmed in the making of this fantasy.
    Last edited by cariaso; 05-07-2008, 04:01 PM.

    Comment

    • apfejes
      Senior Member
      • Feb 2008
      • 236

      #3
      I like cariaso's study, though I'd also do gene expression studies:

      I'd take N drug therapies, and test the whole transcriptome shotgun expression on each of M cell types, on X people, where N, N and X are impossibly large numbers. And, of course, each of the X people would also have a complete genome reference assembled.

      You'd be able to figure out what parts of the genome cause drug interactions (successful, no effect or adverse side effect) if M,N and X were large enough.

      For people who develop resistance, ie. cancer drugs no longer work, I'd also WTSS those tissues before and after resistance occurs to identify mechanisms.

      What fun!
      The more you know, the more you know you don't know. —Aristotle

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        10-14-2026, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 10-15-2026, 10:52 AM
      0 responses
      26 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-14-2026, 05:39 AM
      0 responses
      32 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-13-2026, 09:56 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-09-2026, 11:14 AM
      0 responses
      28 views
      0 reactions
      Last Post SEQadmin2  
      Working...